Skip to main content
PolicySpeak
← All files
DNV

DNV

Company · Norway · EU Transparency Register 414057515145-62

2
positions filed
in the 326 files tracked
2
legislative files
of 326 tracked
1
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 925 companies & groups on this site, they rank #395 by legislative files engaged — a count of participation, not a measure of influence.

2
declared lobbying FTE
self-declared
€200K+
declared costs / yr (floor)
1
EP accreditations
as declared to the register
2014
in the register since

Declares membership of

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).

Register category
Companies & groups
Head office
Høvik, Norway

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track DNV in PolicySpeak: request access →

Work at DNV? so we know who speaks for it.

Follow the files DNV engages with

One email on Tuesdays when a new position is filed on these 2 files, from DNV or from anyone else on them. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

DNV filed 2 positions between 8 Jun 2026 and 10 Jun 2026, across 2 of the 326 legislative files tracked here, attaching a full position paper 1 time.

What they argued

Simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and support of the European Medicines Agency for the expert panels on medical devices and the list of Union harmonisation legislationfiled 8 Jun 2026PDFsource

DNV's full contribution is attached, and summarized hereafter. DNV welcomes the European Commissions effort to revisit Regulation (EU) 2017/745 (MDR) in order to improve implementation, reduce avoidable burden and support timely access to safe and effective medical devices and in vitro diagnostics in the European Union.

Carbon price paid in a third country under the carbon border adjustment mechanism (CBAM)filed 10 Jun 2026source

DNV welcomes the opportunity to provide input on the draft implementing regulation concerning the recognition of carbon prices paid in third countries under the Carbon Border Adjustment Mechanism (CBAM). The proposal represents an important step towards ensuring that carbon costs borne outside the EU are appropriately accounted for, while maintaining the environmental integrity of CBAM.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Turns up on the same files

Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.

Is this your organization?

Everything on this page comes from DNV’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.